Bioverativ Competitors and Similar CompaniesClear all
Bioverativ's competitors and similar companies include Polyplus-transfection, Acorda Therapeutics, Codiak Biosciences and Right To Care.
 Bioverativ Bioverativ is a biotechnology company that is focused on the discovery, research, development and commercialization of therapies for the treatment of hemophilia and other blood disorders. |  Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. |  Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. |  Right To Care Right To Care is a non-profit organization that supports and delivers prevention, care, and treatment for HIV and associated diseases in South Africa. | |
Founding Date | Founding Date 2017 | Founding Date 2002 | Founding Date 1995 | Founding Date 2015 | Founding Date 2001 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Waltham, US HQ Kew, AU Mississauga, CA Chūō Ku, JP South San Francisco, US | Locations Illkirch-Graffenstaden, FR HQ New York, US | Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US | Locations Cambridge, US HQ | |
Employees | Employees 350 | Employees 1133% increase | Employees 4742% decrease | Employees 992% decrease | Employees 1,817 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 821 k | Valuation ($) 2.8 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $117.6m (FY, 2023) | Revenue (est.) $22.9m (FY, 2021) | Revenue (est.) N/A |
Net income | Net income N/A | Net income N/A | Net income ($252.9m) (FY, 2023) | Net income ($37.2m) (FY, 2021) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 3.2m | Total funding raised N/A | Total funding raised $ 168.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Polyplus-transfection
HQ
Illkirch-Graffenstaden, FR
Employees
113↑ 3% increase
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View companyAcorda Therapeutics
HQ
Ardsley, US
Employees
474↓ 2% decrease
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
View companyCodiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View companyRight To Care
HQ
Centurion, ZA
Employees
1,817
Right To Care is a non-profit organization that supports and delivers prevention, care, and treatment for HIV and associated diseases in South Africa.
View company